🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Treatment Acquiring Traction Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are urged to contact these accounts privately for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a robust trade exists on messaging services, where groups with numerous of members share “before and after” images, administration instructions and claims of next-day British shipping. Sellers promote the drug there before directing buyers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Express Worries

Nevertheless, physicians and chemists have cautions that the distribution of what remains an unlicensed drug in the UK is worrisome and could result in individuals administering substances of unknown origin.

Some professionals said the popularity for the experimental drug could be connected to the rising cost of licensed slimming products such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be marketed or distributed for human use under the British medical regulations.

Several influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to fines, prosecution or prison.

Platform Response and Content Elimination

According to the social media company, the platform has taken down violative content and prohibited associated keywords and search suggestions. The organization said it was dedicated to keeping the service secure and allocating resources in enhancing compliance measures.

Digital Trading Operations

Investigations also found communities with up to nine thousand members selling retatrutide using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with numerous of members, populated with photos of slimming results, glowing testimonials and detailed guides for preparing or administering at home.

After minutes of entering one community, a vendor posted contact information, where most purchases occur. The vendor sent an guidebook and promised shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about weight, health issues or past usage.

Product Information and Pricing

Within these groups, posts show dark colored packages with postal service labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When questioned how much time a injector should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A representative for Telegram said it regularly monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting materials they can’t verify. Although the science behind retatrutide is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered individuals harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject users to potentially serious health risks”.